Sex-Related Differences and Predictors of Mortality in Patients Undergoing Major Orthopaedic Surgery: Insights from the ORTHO-START Registry.

IF 4.2 2区 医学 Q2 HEMATOLOGY
Elvira Grandone, Emilia Antonucci, Gregory Piazza, Doris Barcellona, Carlo Rostagno, Donatella Colaizzo, Antonio de Laurenzo, Giovanni di Rienzo, Francesco Gorgoglione, Giuseppe Maccagnano, Francesco Marongiu, Mario Mastroianno, Marco Marzolo, Lucia Mirabella, Biagio Moretti, Anna M Moretti, Angelo Ostuni, Gualtiero Palareti, Maurizio Margaglione
{"title":"Sex-Related Differences and Predictors of Mortality in Patients Undergoing Major Orthopaedic Surgery: Insights from the ORTHO-START Registry.","authors":"Elvira Grandone, Emilia Antonucci, Gregory Piazza, Doris Barcellona, Carlo Rostagno, Donatella Colaizzo, Antonio de Laurenzo, Giovanni di Rienzo, Francesco Gorgoglione, Giuseppe Maccagnano, Francesco Marongiu, Mario Mastroianno, Marco Marzolo, Lucia Mirabella, Biagio Moretti, Anna M Moretti, Angelo Ostuni, Gualtiero Palareti, Maurizio Margaglione","doi":"10.1055/a-2918-4154","DOIUrl":null,"url":null,"abstract":"<p><strong>Abstract: </strong>Sex-related differences in outcomes after major orthopaedic surgery remain under-investigated, and the prognostic relevance of a history of venous thromboembolism (VTE) is unclear. The ORTHO-START registry is a prospective, multicenter study including 1,077 consecutive adults undergoing major orthopaedic surgery (elective hip/knee arthroplasty or urgent hip fracture repair) across six Italian centers between July 2018 and March 2022. Baseline characteristics, perioperative complications, and antithrombotic therapy were collected. The primary outcome was all-cause mortality at 24 months; secondary outcomes were thromboembolic and bleeding events. Multivariable logistic regression identified predictors of mortality. Women represented 72.3% (<i>n</i> = 775) of the cohort and were older than men (80.6 ± 10.0 vs. 76.2 ± 13.0 years, <i>p</i> < 0.001). Urgent procedures comprised 65.6% (<i>n</i> = 706) of surgeries, predominantly involving women (<i>n</i> = 542). At 24 months, mortality was higher in men (31 vs. 18%, <i>p</i> = 0.018). Independent predictors of mortality included male sex (odds ratio [OR] = 2.6, 95% confidence interval [CI]: 1.8-4.0), older age, lower body mass index, urgent surgery (OR = 7.2, 95% CI: 4.1-12.4), and prior VTE (OR = 5.7, 95% CI: 1.4-23.9). Causes of death were known for 160/210 (76.2%): neurological complications were most frequent (25%), followed by cardiovascular disease (21.3%) and immobility-related causes (14.4%); pulmonary embolism accounted for 1.3% of deaths. Thrombotic and hemorrhagic events occurred in both sexes without significant differences. Male sex and a history of VTE are independent predictors of long-term mortality following major orthopaedic surgery. Incorporating these factors into preoperative risk assessment may improve management and postoperative outcomes.</p>","PeriodicalId":21673,"journal":{"name":"Seminars in thrombosis and hemostasis","volume":" ","pages":""},"PeriodicalIF":4.2000,"publicationDate":"2026-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in thrombosis and hemostasis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2918-4154","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract: Sex-related differences in outcomes after major orthopaedic surgery remain under-investigated, and the prognostic relevance of a history of venous thromboembolism (VTE) is unclear. The ORTHO-START registry is a prospective, multicenter study including 1,077 consecutive adults undergoing major orthopaedic surgery (elective hip/knee arthroplasty or urgent hip fracture repair) across six Italian centers between July 2018 and March 2022. Baseline characteristics, perioperative complications, and antithrombotic therapy were collected. The primary outcome was all-cause mortality at 24 months; secondary outcomes were thromboembolic and bleeding events. Multivariable logistic regression identified predictors of mortality. Women represented 72.3% (n = 775) of the cohort and were older than men (80.6 ± 10.0 vs. 76.2 ± 13.0 years, p < 0.001). Urgent procedures comprised 65.6% (n = 706) of surgeries, predominantly involving women (n = 542). At 24 months, mortality was higher in men (31 vs. 18%, p = 0.018). Independent predictors of mortality included male sex (odds ratio [OR] = 2.6, 95% confidence interval [CI]: 1.8-4.0), older age, lower body mass index, urgent surgery (OR = 7.2, 95% CI: 4.1-12.4), and prior VTE (OR = 5.7, 95% CI: 1.4-23.9). Causes of death were known for 160/210 (76.2%): neurological complications were most frequent (25%), followed by cardiovascular disease (21.3%) and immobility-related causes (14.4%); pulmonary embolism accounted for 1.3% of deaths. Thrombotic and hemorrhagic events occurred in both sexes without significant differences. Male sex and a history of VTE are independent predictors of long-term mortality following major orthopaedic surgery. Incorporating these factors into preoperative risk assessment may improve management and postoperative outcomes.

大骨科手术患者的性别相关差异和死亡率预测因素:来自ORTHO-START登记的见解。
摘要:重大骨科手术后预后的性别差异仍未得到充分研究,静脉血栓栓塞(VTE)史与预后的相关性尚不清楚。ORTHO-START注册是一项前瞻性多中心研究,包括2018年7月至2022年3月期间在意大利六个中心连续接受重大骨科手术(选择性髋关节/膝关节置换术或紧急髋部骨折修复)的1,077名成年人。收集基线特征、围手术期并发症和抗血栓治疗情况。主要结局是24个月时的全因死亡率;次要结局是血栓栓塞和出血事件。多变量逻辑回归确定了死亡率的预测因子。女性占队列的72.3% (n = 775),手术年龄大于男性(80.6±10.0岁vs 76.2±13.0岁,p n = 706),主要涉及女性(n = 542)。在24个月时,男性的死亡率更高(31%比18%,p = 0.018)。死亡率的独立预测因素包括男性(比值比[OR] = 2.6, 95%可信区间[CI]: 1.8-4.0)、年龄较大、体重指数较低、紧急手术(OR = 7.2, 95% CI: 4.1-12.4)和既往静脉血栓栓塞(OR = 5.7, 95% CI: 1.4-23.9)。已知的死亡原因为160/210(76.2%):最常见的是神经系统并发症(25%),其次是心血管疾病(21.3%)和行动不便相关原因(14.4%);肺栓塞占死亡人数的1.3%。两性发生血栓和出血事件无显著差异。男性性别和静脉血栓栓塞史是重大骨科手术后长期死亡率的独立预测因素。将这些因素纳入术前风险评估可以改善管理和术后结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Seminars in thrombosis and hemostasis
Seminars in thrombosis and hemostasis 医学-外周血管病
CiteScore
8.80
自引率
21.10%
发文量
132
审稿时长
6-12 weeks
期刊介绍: Seminars in Thrombosis and Hemostasis is a topic driven review journal that focuses on all issues relating to hemostatic and thrombotic disorders. As one of the premiere review journals in the field, Seminars in Thrombosis and Hemostasis serves as a comprehensive forum for important advances in clinical and laboratory diagnosis and therapeutic interventions. The journal also publishes peer reviewed original research papers. Seminars offers an informed perspective on today''s pivotal issues, including hemophilia A & B, thrombophilia, gene therapy, venous and arterial thrombosis, von Willebrand disease, vascular disorders and thromboembolic diseases. Attention is also given to the latest developments in pharmaceutical drugs along with treatment and current management techniques. The journal also frequently publishes sponsored supplements to further highlight emerging trends in the field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书